Skip to main content
. 2020 Apr 3;8:134. doi: 10.3389/fped.2020.00134

Table 2.

Subgroup analysis for asthma/wheeze base on categorical BMI (adjusted).

Group Numbers
(Asthma/Wheeze)
Asthma Wheeze
OR (95% CI); P I2 OR (95% CI); P I2
Maternal obesity
By sample size
   Total sample size <6000 3/7 1.60 (1.20–2.13); 0.001 48.6% 1.68 (1.25–2.26); 0.001 73.0%
   Total sample size ≥6000 3/6 1.50 (1.34–1.66); <0.001 0.0% 1.28 (1.10–149); 0.001 44.9%
By region
   America 3/2 1.39 (1.20–1.60); <0.001 0.0% 3.12 (1.74–5.13); <0.001 0.0%
   Asia NA/1 NA NA 1.67 (0.73–3.81); 0.223 NA
   Europe 3/10 1.63 (1.38–1.94); <0.001 19.4% 1.29 (1.14–1.45); <0.001 56.2%
By weight modality
   Medical records 2/4 1.40 (1.12–1.74); 0.003 0.0% 1.24 (1.00–1.55); 0.052 32.7%
   Self-report 4/9 1.54 (1.34–1.77); <0.001 32.3% 1.48 (1.22–1.79); <0.001 70.4%
By diagnosis of asthma
   Doctor diagnosis 5/5 1.50 (1.33–1.69); <0.001 23.9% 1.48 (1.19–1.86); 0.001 36.1%
   Parental report 1/8 1.53 (1.04–2.26); 0.032 NA 1.29 (1.11–1.51); 0.001 63.0%
Maternal overweight
By sample size
   Total sample size <6000 4/8 1.19 (0.95–1.49); 0.123 47.1% 1.19 (0.95–1.49); 0.032 0.0%
   Total sample size ≥6000 3/5 1.21 (1.13–1.30); <0.001 0.0% 1.21 (1.13–1.30); 0.022 41.9%
By region
   America 2/1 1.20 (1.06–1.38); 0.005 0.0% 1.58 (0.75–3.31); 0.226 NA
   Asia NA/1 NA NA 1.11 (0.72–1.71); 0.635 NA
   Europe 5/11 1.21 (1.06–1.37); 0.004 30.9% 1.07 (1.02–1.11); 0.003 0.0%
By weight modality
   Medical records 1/3 1.14 (0.90–1.45); 0.282 NA 1.12 (1.03–1.23); 0.013 0.0%
   Self-report 6/10 1.21 (1.12–1.31); <0.001 10.6% 1.06 (1.01–1.12); 0.028 2.7%
By diagnosis of asthma
   Doctor diagnosis 4/4 1.22 (1.14–1.31); <0.001 0.0% 1.16 (1.03–1.30); 0.013 0.0%
   Parental report 3/9 1.14 (0.86–1.51); 0.362 57.9% 1.06 (1.01–1.10); 0.019 0.0%

BMI, body mass index; OR, odds ratio; 95% CI, 95% confidence interval; I2, inconsistency index; NA, not available.